Almac to offer GMP peptide manufacturing services for cancer vaccines
Almac Group will commence GMP supply of neoantigen-derived peptides for use in individualized cancer vaccine production later this year.
Almac Group will commence GMP supply of neoantigen-derived peptides for use in individualized cancer vaccine production later this year.
LabCorp signed several partnership deals in the second quarter of 2018 as the company aims to enhance the drug development process and continues to invest in its CRO business.
The MHRA has issued guidance outlining how UK pharma would be affected during the Brexit implementation period, due to be finalised in the Withdrawal Agreement come October.
Sun Pharma has announced that its Kapspargo Sprinkle product, an extended-release heart drug, has been launched in the US market.
FDA declines the approval of Pain Therapeutics abuse-deterrent opioid treatment for the fourth time.
Verana Health raises $30m in a Series C financing round to expand its data platform and build out its medical informatics and technology team.
Scientist.com’s partnership with ZenBio will provide users of the online marketplace access to human skin tissue.